Ready for Prime Time? Biomarkers in Sepsis

Area of Science:

• Emergency Medicine
• Infectious Diseases
• Clinical Pathology

Background:

• Sepsis is a frequent emergency department presentation.
• Current sepsis diagnosis involves clinical assessment and diagnostic studies to identify infection source.
• The host's response to infection is measurable and can serve as a diagnostic indicator.

Purpose of the Study:

• To discuss the utility of current sepsis biomarkers.
• To explore novel biomarkers for sepsis diagnosis.
• To enhance early sepsis detection and clinical decision-making.

Main Methods:

• Review of existing literature on sepsis biomarkers.
• Discussion of lactate, procalcitonin, and troponin in sepsis.
• Exploration of emerging biomarkers for sepsis.

Main Results:

• Lactate, procalcitonin, and troponin are established sepsis biomarkers.
• Novel biomarkers show potential for improved sepsis diagnosis and management.
• Biomarker utility aids in risk stratification and clinical decision support.

Conclusions:

• Reliable biomarkers are crucial for timely sepsis diagnosis and management.
• Evaluating current and novel biomarkers can optimize emergency department sepsis protocols.
• Improved diagnostic tools lead to better patient outcomes in sepsis cases.